Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sandostatin LAR in Acromegaly
NCT01424241Phase 4Completed
- Sponsor
- Columbia University
- Start
- Oct 2006
- Primary completion
- Mar 2013
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of octreotide in acromegaly, sponsored by Columbia University. Started Oct 2006; status: completed.
02
Drugs
octreotide
03
Conditions
acromegaly
Beyond the preview
Go deeper on NCT01424241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01424241.